IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $90,532,553 |
| Submission deadline | Deadline not published |
| Published | Sep 25, 2019 |
| Buyer | National Institutes of Health |
| Country | United States · WA |
| CPV code | NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTEC) · PSC AN12 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $90,532,553
- Submission deadline
- Deadline not published
- Published
- Sep 25, 2019
- Country
- United States
- CPV code
- NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTEC) · PSC AN12
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| SEATTLE CHILDREN'S HOSPITAL | US-UEI: SZ32VTCXM799 | United States | $90,532,553 | Sep 25, 2019 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
Awarding Agency: Department of Health and Human Services — National Institutes of Health.
NAICS 541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY).
PSC AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Period of Performance: 2019-09-30 to 2027-09-29.